Matches in Wikidata for { <http://www.wikidata.org/entity/Q94405829> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q94405829 description "article scientifique publié en 2017" @default.
- Q94405829 description "wetenschappelijk artikel" @default.
- Q94405829 description "наукова стаття" @default.
- Q94405829 name "IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE" @default.
- Q94405829 name "IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE" @default.
- Q94405829 type Item @default.
- Q94405829 label "IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE" @default.
- Q94405829 label "IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE" @default.
- Q94405829 prefLabel "IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE" @default.
- Q94405829 prefLabel "IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE" @default.
- Q94405829 P1433 Q94405829-45D3F7F0-1D4B-4547-B2C4-5C8E4926179A @default.
- Q94405829 P1476 Q94405829-FFA60676-CA00-47AA-BF58-9CA4F1018B1E @default.
- Q94405829 P2093 Q94405829-07AD873D-FD76-4E65-A77C-8D4E5701CB21 @default.
- Q94405829 P2093 Q94405829-204AA1CA-4A34-4E70-AFD8-AFD9AB7400D3 @default.
- Q94405829 P2093 Q94405829-31760BD4-EC15-43B8-8337-F37957555959 @default.
- Q94405829 P2093 Q94405829-4209A86C-6291-457B-ABC9-838DFB14CB56 @default.
- Q94405829 P2093 Q94405829-4AC68CB1-FFEF-4D89-AF34-9C5359D59679 @default.
- Q94405829 P2093 Q94405829-7F94B23F-EC8E-4BDA-B01A-39BA41CA17C0 @default.
- Q94405829 P2093 Q94405829-878427E1-B9FB-4209-9C6C-EAB66EA8A784 @default.
- Q94405829 P2093 Q94405829-CECE61C0-3A34-4EFC-857A-924CA4CD1CA6 @default.
- Q94405829 P304 Q94405829-C6008A57-C79B-49AA-993D-37F2EBD2FDCB @default.
- Q94405829 P31 Q94405829-7932E7C1-8659-4959-BF2E-C3BDC43B2B89 @default.
- Q94405829 P356 Q94405829-E724F8A4-37B0-4ACD-8757-3D2472C77B17 @default.
- Q94405829 P433 Q94405829-60E43DD3-EA11-4843-8158-5B59D7E2B0FC @default.
- Q94405829 P478 Q94405829-45385AC9-DB90-4F39-89C9-61E62F3E1ABE @default.
- Q94405829 P577 Q94405829-7ACE8834-21B4-4E7C-BA7C-75F1A7E79EF7 @default.
- Q94405829 P932 Q94405829-5BC0BEF7-C50F-46CB-B2E0-61B9D4F4BD78 @default.
- Q94405829 P356 NOX168.513 @default.
- Q94405829 P1433 Q15724471 @default.
- Q94405829 P1476 "IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE" @default.
- Q94405829 P2093 "Dominic Maggio" @default.
- Q94405829 P2093 "Herui Wang" @default.
- Q94405829 P2093 "John Heiss" @default.
- Q94405829 P2093 "Kovach John" @default.
- Q94405829 P2093 "Mark R Gilbert" @default.
- Q94405829 P2093 "Rongze Lu" @default.
- Q94405829 P2093 "Winson SC Ho" @default.
- Q94405829 P2093 "Zhengping Zhuang" @default.
- Q94405829 P304 "vi125-vi125" @default.
- Q94405829 P31 Q13442814 @default.
- Q94405829 P356 "10.1093/NEUONC/NOX168.513" @default.
- Q94405829 P433 "Suppl 6" @default.
- Q94405829 P478 "19" @default.
- Q94405829 P577 "2017-11-06T00:00:00Z" @default.
- Q94405829 P932 "5692410" @default.